EPIX Pharmaceuticals, Inc. (fka EPIX)

[retireat40]

Newton, MA-based Karyopharm Therapeutics has completed a $20 million Series A round of financing with the help of unidentified backers, according to a company press release. The developer was founded in 2009 after Epix Pharmaceuticals went bankrupt and liquidated all its assets. Karyopharm's co-founder and COS Sharon Shacham was a senior vice president at Epix when the company went under; former Epix CEO Michael Kauffman is on the company's board

The only connection between Epix and Karyopharm is personnel. Nothing else for now.